Treatment for Psychostimulants and for Co-Morbid Psychiatric and Medical Disorders Are Discussed by Experts from the Central Asian States
Vietnamese Policymakers Attend UNODC Training on the Nature, Prevention and Treatment of Drug Use Disorders
iCADD is hosting the largest European conference on addiction, behaviour, and emotional wellbeing.
Join iCADD for 3 days of networking, furthering global connection, communication and understanding in the prevention and treatment of Behavioral, Mental and Emotional Health, facilitated by world-renowned speakers on our uniquely eclectic combination of topics.
Using the CONSORT Statement to Evaluate the Completeness of Reporting of Addiction Randomised Trials: A Cross-Sectional Review
Objectives: Evaluate the completeness of reporting of addiction randomised controlled trials (RCTs) using the Consolidated Standards of Reporting Trials (CONSORT) statement.
Setting: Not applicable.
Participants: RCTs identified using a PubMed search of 15 addiction journals and a 5-year cross-section.
The drug use landscape is dynamic and changing. Changes in public attitudes and laws towards drug use have occurred in an increasing number of countries.
Global drug production and consumption are increasing as are the risks and harms to health, while new substances continue to emerge. This Series focuses on opioids, cannabinoids, stimulants, and new psychoactive substances.
Coalesce Research Group is delighted to invite you to our International Conference on Addiction, Psychiatry and Mental Health on November 11-12, 2019 at Mercure Roma West, Rome, Italy.
The theme of the event is “Novel approaches and Developments in Addiction Research and Psychiatry”.